Gedeon Richter PLC (BUD:RICHTER)
11,880
+70 (0.59%)
At close: Mar 13, 2026
Revenue by Segment
Financials in millions HUF. Fiscal year is January - December.
Millions HUF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Pharmaceuticals - Neuropsychiatry (CNS) | 264.70B | 242.75B | 205.66B | 145.90B | - | |||||
Pharmaceuticals - Neuropsychiatry (CNS) Growth | 9.04% | 18.03% | 40.96% | - | - | |||||
Pharmaceuticals - Women's Healthcare (WHC) | 328.60B | 286.22B | 255.67B | 229.21B | - | |||||
Pharmaceuticals - Women's Healthcare (WHC) Growth | 14.81% | 11.95% | 11.55% | - | - | |||||
Pharmaceuticals - Biotechnology (BIO) | 64.20B | 54.01B | 46.20B | 41.19B | - | |||||
Pharmaceuticals - Biotechnology (BIO) Growth | 18.86% | 16.91% | 12.18% | - | - | |||||
Pharmaceuticals - General Medicines (GM) | 249.50B | 250.71B | 226.89B | 225.92B | - | |||||
Pharmaceuticals - General Medicines (GM) Growth | -0.48% | 10.50% | 0.43% | - | - | |||||
Pharmaceuticals - Pharma Other | 7.00B | 11.12B | 13.02B | 14.13B | - | |||||
Pharmaceuticals - Pharma Other Growth | -37.04% | -14.61% | -7.87% | - | - | |||||
Other | 25.60B | 24.98B | 70.87B | 164.29B | 7.15B | |||||
Other Growth | 2.49% | -64.76% | -56.86% | 2197.72% | 3.34% | |||||
Eliminations | -10.60B | -12.24B | -13.16B | -17.88B | -15.79B | |||||
Pharmaceuticals | - | - | - | - | 505.02B | |||||
Pharmaceuticals Growth | - | - | - | - | 10.44% | |||||
Wholesale and Retail | - | - | - | - | 134.21B | |||||
Wholesale and Retail Growth | - | - | - | - | 12.05% | |||||
Total | 929.00B | 857.55B | 805.16B | 802.76B | 630.60B | |||||
Total Growth | 8.33% | 6.51% | 0.30% | 27.30% | 11.26% |
Revenue by Geography
Financials in millions HUF. Fiscal year is January - December.
Millions HUF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Western Europe | 179.00B | - | - | - | - | |||||
Central Europe | 176.40B | - | - | - | - | |||||
Eastern Europe | 185.80B | - | - | - | - | |||||
North America | 276.40B | 255.34B | 221.19B | 165.98B | - | |||||
North America Growth | 8.25% | 15.44% | 33.26% | - | - | |||||
Asia & Pacific | 54.70B | - | - | - | - | |||||
Latin America | 32.60B | 35.53B | 31.68B | 27.88B | 17.60B | |||||
Latin America Growth | -8.25% | 12.15% | 13.63% | 58.40% | 60.03% | |||||
Rest of The World | 9.00B | 6.71B | 8.26B | 6.44B | 31.24B | |||||
Rest of The World Growth | 34.21% | -18.83% | 28.31% | -79.39% | 13.76% | |||||
Europe | - | 511.36B | 500.96B | 563.38B | 263.44B | |||||
Europe Growth | - | 2.08% | -11.08% | 113.85% | 15.78% | |||||
APAC | - | 48.62B | 43.07B | 39.08B | - | |||||
APAC Growth | - | 12.88% | 10.21% | - | - | |||||
Hungary | - | - | - | - | 44.38B | |||||
Hungary Growth | - | - | - | - | 5.94% | |||||
United States of America | - | - | - | - | 122.99B | |||||
United States of America Growth | - | - | - | - | 13.35% | |||||
China | - | - | - | - | 15.59B | |||||
China Growth | - | - | - | - | 44.85% | |||||
CIS (Commonwealth of Independent States) | - | - | - | - | 135.35B | |||||
CIS (Commonwealth of Independent States) Growth | - | - | - | - | -3.06% | |||||
Total | 913.90B | 857.55B | 805.16B | 802.76B | 630.60B | |||||
Total Growth | 6.57% | 6.51% | 0.30% | 27.30% | 11.26% |
Source: S&P Global Market Intelligence.